Literature DB >> 14226092

A HEMODILUTION TECHNIQUE FOR OPEN-HEART SURGERY: A PRELIMINARY CLINICAL REPORT.

K KELKAR, G B PALOSCHI, R O WEST, G R HORNE, R B LYNN.   

Abstract

With the extension of open-heart procedures and the increasing success of open-heart surgery, a great strain has been placed on many hospital laboratories and on the Red Cross for the maintenance of equipment and the supply of blood. In order to decrease both of these needs, hemodilution techniques combined with disposable oxygenators have been introduced. The authors have used a disposable oxygenator with low molecular weight dextran prime, along with moderate hypothermia, in a consecutive series of 15 patients operated upon for congenital and acquired heart lesions. In this consecutive series there has been one death and this could not be attributed to the perfusion technique but to the surgical procedure carried out. It is felt that this combination not only broadens the horizons of open-heart surgery but makes the procedure more readily available and safer, as well as being economical of blood donors and time.

Entities:  

Keywords:  ADOLESCENCE; DEXTRAN; EQUIPMENT AND SUPPLIES; HEART SEPTAL DEFECTS, ATRIAL; HEART SURGERY; HEART, MECHANICAL; HYPOTHERMIA, INDUCED; PERFUSION; TECHNOLOGY, MEDICAL

Mesh:

Substances:

Year:  1964        PMID: 14226092      PMCID: PMC1928511     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  BLOOD-LOSS AFTER CARDIOPULMONARY BYPASS.

Authors:  B SMITH; D G MELROSE; M A OMERI; H H BENTALL; S ALLWORK
Journal:  Lancet       Date:  1964-08-08       Impact factor: 79.321

2.  HEMODILUTION IN EXTRACORPORAL CIRCULATION: COMPARATIVE STUDY OF LOW MOLECULAR WEIGHT DEXTRAN AND 5 PERCENT DEXTROSE.

Authors:  L C MAINARDI; K BHANGANADA; J D MACK; C W LILLEHEI
Journal:  Surgery       Date:  1964-08       Impact factor: 3.982

3.  Simplified total body perfusion. Reduced flows, moderate hypothermia, and hemodilution.

Authors:  R A DEWALL; C W LILLEHEI
Journal:  JAMA       Date:  1962-02-10       Impact factor: 56.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.